Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial
Makaleler > Tam Makale · 2011
Yazarlar: ERICH V. DE PAULA, KAAN KAVAKLI, JOHNNY MAHLANGU, YASMIN AYOB, STEVEN R. LENTZ, MASSIMO MORFINI, LÁSZLÓ NEMES, SILVA Z. ŠALEK, MIDORI SHIMA, JERZY WINDYGA, SILKE EHRENFORTH, AMPAIWAN CHUANSUMRIT
Journal of Thrombosis and Haemostasis, Uluslararası, Wos, 2011, cilt 10, ss 81-89